- Home
- TCBIO vs XOMAP Comparison
TCBIO vs XOMAP Comparison
Compare TCBIO & XOMAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
TCBIO
Texas Capital Bancshares Inc. Depositary Shares 5.75% Fixed Rate Non-Cumulative Perpetual Preferred Stock Series B
Current Price
Company Overview
Basic Information| Metric | TCBIO | XOMAP |
|---|---|---|
| Founded | N/A | N/A |
| Country | United States | United States |
| Employees | 1785 | 14 |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | N/A |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | TCBIO | XOMAP |
|---|---|---|
| Price | $21.51 | $25.27 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 13.6K | 5.0K |
| Earning Date | N/A | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $19.70 | $25.14 |
| 52 Week High | $22.95 | $27.30 |
Technical Indicators
Market Signals| Indicator | TCBIO | XOMAP |
|---|---|---|
| Relative Strength Index (RSI) | 39.64 | 40.82 |
| Support Level | $20.33 | $25.15 |
| Resistance Level | $21.75 | $26.12 |
| Average True Range (ATR) | 0.30 | 0.17 |
| MACD | -0.01 | -0.05 |
| Stochastic Oscillator | 18.29 | 11.46 |
Price Performance
Historical ComparisonAbout TCBIO Texas Capital Bancshares Inc. Depositary Shares 5.75% Fixed Rate Non-Cumulative Perpetual Preferred Stock Series B
Texas Capital Bancshares Inc is a registered bank holding company and a full-service financial services firm that delivers customised solutions to businesses, entrepreneurs and individual customers. It is a secured lender with the majority of the loans held for investment, excluding mortgage finance loans and other national lines of business. Texas Capital has established commercial banking, consumer banking, investment banking and wealth management capabilities.
About XOMAP XOMA Corporation 8.625% Series A Cumulative Perpetual Preferred Stock
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates. The Company's drug royalty aggregator business is mainly focused on the acquisition of early to mid-stage clinical assets. Geographically, the company operates in Switzerland, the United States, Asia Pacific, Europe, and other regions.